114 related articles for article (PubMed ID: 8089500)
21. Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
Heidecke CD; Kupiec-Weglinski JW; Lear PA; Abbud-Filho M; Araujo JL; Araneda D; Strom TB; Tilney NL
J Immunol; 1984 Aug; 133(2):582-8. PubMed ID: 6234351
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
23. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice.
Dai Z; Konieczny BT; Baddoura FK; Lakkis FG
J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028
[TBL] [Abstract][Full Text] [Related]
24. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
25. Soluble antigen and cyclosporine-induced specific unresponsiveness in rats. Frequency of alloantigen-specific T cytotoxic cells in normal, sensitized, and unresponsive rats.
Ito T; Stepkowski SM; Kahan BD
Transplantation; 1990 Feb; 49(2):422-8. PubMed ID: 2137656
[TBL] [Abstract][Full Text] [Related]
26. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
Tu Y; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
[TBL] [Abstract][Full Text] [Related]
27. The immunosuppressive action of suppressor cells from antigen-cyclosporine-treated hosts on renal allograft survival.
Yoshimura N; Kahan BD
Transplantation; 1985 Oct; 40(4):384-9. PubMed ID: 2413593
[TBL] [Abstract][Full Text] [Related]
28. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity.
Chen Z; Lu L; Zhang H; Dean NM; Fung JJ; Qian S
Microsurgery; 2003; 23(5):494-7. PubMed ID: 14558009
[TBL] [Abstract][Full Text] [Related]
29. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
Boyle MJ; Dumble LJ
Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
[TBL] [Abstract][Full Text] [Related]
30. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
[TBL] [Abstract][Full Text] [Related]
31. Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells.
Clason AE; Duarte AJ; Kupiec-Weglinski JW; Williams JN; Wang BS; Strom TB; Tilney NL
J Immunol; 1982 Jul; 129(1):252-9. PubMed ID: 7045223
[TBL] [Abstract][Full Text] [Related]
32. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
Abbud-Filho M; Kupiec-Weglinski JW; Araujo JL; Heidecke CD; Tilney NL; Strom TB
J Immunol; 1984 Nov; 133(5):2582-6. PubMed ID: 6237152
[TBL] [Abstract][Full Text] [Related]
34. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
[No Abstract] [Full Text] [Related]
35. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.
Chen H; Luo H; Daloze P; Xu D; Shan X; St-Louis G; Wu J
Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391
[TBL] [Abstract][Full Text] [Related]
36. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
37. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.
Stepkowski SM; Chen H; Daloze P; Kahan BD
Transplantation; 1991 Jan; 51(1):22-6. PubMed ID: 1987691
[TBL] [Abstract][Full Text] [Related]
38. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
Yoshimura N; Kahan BD
Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
[TBL] [Abstract][Full Text] [Related]
39. Cytokine mRNA expression in tolerant heart allografts after immunosuppression with cyclosporine, sirolimus or brequinar.
Tian L; Stepkowski SM; Qu X; Wang ME; Wang M; Yu J; Kahan BD
Transpl Immunol; 1997 Sep; 5(3):189-98. PubMed ID: 9402685
[TBL] [Abstract][Full Text] [Related]
40. Immune mechanisms in organ allograft rejection. II. T helper cells, delayed-type hypersensitivity, and rejection of renal allografts.
Gurley KE; Lowry RP; Forbes RD
Transplantation; 1983 Oct; 36(4):401-5. PubMed ID: 6226134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
